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Résumé 
Le PESI (Pulmonary Embolism Severity Index) est un score clinique pronostique 
s'appliquant à des patients présentant un diagnostic d'embolie pulmonaire. Notre 
objectif était de démontrer la reproductibilité de ce score entre différents médecins 
chez des patients présentant une embolie pulmonaire. Nous avons donc identifié, de 
façon prospective, des patients présentant une embolie pulmonaire nouvellement 
diagnostiquée aux urgences d'un Hôpital Universitaire (CHUV, Lausanne). Pour tous 
ces patients, le médecin assistant en charge ainsi que le chef de clinique superviseur 
ont individuellement collecté les différentes variables permettant d'établir le score 
selon le PESI. Ils ont, ensuite, de façon indépendante, classifié les patients dans 5 
classes de risque (1-V) ainsi qu'en deux groupes à bas risque versus haut risque, 
respectivement les classes 1-11 et les classes 111 à V. 
Nous avons examiné la reproductibilité des données entre deux groupes de 
médecins (médecins assistants vs chefs de clinique), pour chacune des variables 
constituant le PESI, pour le score total en points, pour l'attribution aux 5 classes de 
risque ainsi que pour la classification en deux groupes à haut risque versus bas 
risque. Cette évaluation de la reproductibilité des résultats obtenus par les différents 
médecins s'est basée sur le calcul du Kappa (K) ainsi sur les Coefficients de 
Corrélation lntra-classe (ICC). 
Parmi les 48 patients présentant une Embolie Pulmonaire inclus dans notre étude, 
les coefficients de reproductibilité entre médecins assistants et chefs de clinique 
étaient supérieurs à 0.60 pour 10 des 11 variables du PESI. La reproductibilité entre 
les 2 groupes de médecins, pour le total des points, pour l'attribution à une classe de 
risque 1 à V, ainsi que pour la classification en bas versus haut risque était presque 
parfaite. 
Nos résultats démontrent la haute reproductibilité du PESI, et appuient donc l'intérêt 
de son utilisation pour la stratification du risque chez des patients présentant une 
embolie pulmonaire. 
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SUMMARY 
The Pulmonary Embolism Severity Index (PESI) is a validated clinical prognostic 
model for patients with acute pulmonary embolism (PE). Our goal was to assess the 
PESl's interrater reliability in patients diagnosed with PE. We prospectively identified 
consecutive patients diagnosed with PE in the emergency department of a Swiss 
teaching hospital. ·For all patients, resident and attending physician raters 
independently collected the 11 PESI variables. The raters then calculated the PESI 
total point score and classified patients into one of five PESI risk classes (1-V) and as 
low (risk classes 1/11) versus higher-risk (risk classes Ill-V). We examined the 
interrater reliability for each of the 11 PESI variables, the PESI total point score, 
assignment to each of the five PESI risk classes, and classification of patients as low 
versus higher-risk using kappa (K) and intraclass correlation coefficients (ICC). 
Among 48 consecutive patients with an objective diagnosis of PE, reliability 
coefficients between resident and attending physician raters were > 0.60 for 10 of the 
11 variables comprising the PESI. The interrater reliability for the PESI total point 
score (ICC: 0.89, 95% Cl: 0.81-0.94), PESI risk class assignment (K: 0.81, 95% Cl: 
0.66-0.94), and the classification of patients as low versus higher-risk (K: 0.92, 95% 
Cl: 0.72-0.98) was near perfect. Our results demonstrate the high reproducibility of 
the PESI, supporting the use of the PESI for risk stratification of patients with PE. 
Key Words: interrater reliability, Pulmonary Embolism Severity Index. 
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The Pulmonary Embolism Severity Index (PESI) is a validated clinical prognostic 
model to identify patients with acute pulmonary embolism (PE) who are at low-risk of 
30-day mortality and other adverse outcomes (1-4). Based on 11 clinical parameters 
readily available at the time of presentation (Table 1 ), a total point score is calculated 
by summing the integer-based prognostic weights of each prognostic variable 
identified for a given patient with PE. On the basis of the total point score, patients 
are classified into five risk classes (1-V) of increasing risk of mortality, ranging from 
1.1 % for patients in class 1 to 24.5% for patients in class V (1 ). Patients in risk 
classes 1 and Il have a very low risk of 30-day mortality and are considered low-risk. 
ln the absence of coexisting illnesses that warrant hospital admission or psychosocial 
conditions that preclude outpatient care, low-risk patients (risk classes 1 and Il) are 
potential candidates for outpatient treatment or an abbreviated hospital stay. Patients 
in risk classes Ill to V have a substantially higher risk for 30-day mortality and should 
be treated in the hospital. Thus, in contrast to other clinical prognostic models for PE, 
the PESI provides clinicians with an easily applied, explicit risk stratification 
instrument, without any need for imaging studies (e.g., echocardiography, 
compression ultrasonography) or laboratory tests (5, 6). The prognostic accuracy of 
the PESI has been validated in multiple retrospective and prospective studies from 
different settings and countries (1-4). 
Current methodological guidelines request that the reproducibility of a 
prediction rule and its individual predictive variables should be assessed before the 
rule can be adopted into clinical practice (7). The goal of our study was to 
prospectively assess the PESl's interrater reliability in patients diagnosed with PE. 
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METHODS 
Patient Identification and Eligibility 
We prospectively identified consecutive patients diagnosed with PE in the 
emergency department (ED) of a Swiss teaching hospital using an electronic patient 
tracking system. Patients aged ~ 18 years who had an objective diagnosis of acute 
PE (positive spiral computed tomography, high-probability ventilation-perfusion lung 
scan, or positive pulmonary angiography) were eligible for the study. There were no 
exclusion criteria . The study was approved by the institutional review board. 
Prospective Data Collection 
For ail eligible patients, the ED residents and attending physicians in charge of 
the patient independently filled out a standardized data collection form. Collected 
data included the rater's age, gender, and years of clinical experience. Based on the 
patient's medical chart, the raters also recorded the diagnostic procedure (positive 
spiral computed tomography, high-probability ventilation-perfusion scan, or positive 
pulmonary angiography) that led to the diagnosis of PE and ail 11 patient parameters 
comprising the PESI (age in years, gender, presence of cancer, heart failure, or 
chronic lung disease, pulse~ 11 O/minute, systolic blood pressure< 1 OO mm Hg, 
respiratory rate~ 30/minute, temperature < 36°C, altered mental status, and arterial 
oxygen saturation < 90%). Parameters that were not documented in the medical 
chart were assumed to be normal by the raters, a strategy successfully used in the 
derivation and validation of the PESI (1, 2, 4) . The raters then calculated the PESI 
total score by summing the patient's age in y.ears and the points for each predictor 
and classified patients into one of five PESI risk classes (1-V) and as low (risk classes 
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1 and Il) versus higher-risk (risk classes Ill-V). The raters were blinded to each other's 
assessment. 
Statistical Analyses 
We compared baseline characteristics of resident and attending physician 
raters using Fisher's exact tests for categorical variables and Wilcoxon rank-sum 
tests for continuous variables. We estimated the interrater reliability between resident 
and attending physician raters for each of the 10 individual categorical PESI 
variables and patient classification as low (risk classes 1-11) versus higher-risk (risk 
classes Ill-V) using the unweighted kappa (K) coefficient (8). We estimated the 
interrater reliability for the five PESI risk classes using the weighted K coefficient (with 
weights 1-li-jl/(k-1 ), where i and j index the rows and columns of the ratings by the 
two raters and k is the maximum number of possible ratings) (9). We also estimated 
interrater agreement for categorical variables using total percent agreement. To 
assess the interrater reliability for continuous variables such as patient age and the 
PESI total point score, we calculated the intraclass correlation coefficient (ICC) (10). 
We classified interrater reliability based on the magnitude of the reliability coefficients 
as follows: 0.0 to 0.19, poor; 0.20 to 0.39, fair; 0.40 to 0.59, moderate; 0.60 to 0.79, 
substantial; and 0.80 to 1.0, almost perfect (11 ). We used linear mixed regression to 
examine the association between the PESI total point score and rater characteristics 
(resident vs attending physician, gender, and years of clinical experience). 
Assuming that 50-70% of patients are classified as higher-risk and a minimally 
acceptable K of 0.4, we calculated that a sample size of 48 subjects with PE with two 
raters per subject would achieve 80% power to detect a K of 0.8 using a two-tailed 
alpha level of 0.05 (12) . Ali analyses were performed using Stata 10.2. 
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RESULTS 
We identified 48 consecutive patients who presented with an objective 
diagnosis of acute PE at the ED between October 2, 2009, and April 7, 201 O. PE was 
diagnosed based on a positive spiral computed tomography in all cases. The median 
age of our study population was 65 years (interquartile range: 48 to 77 years); 56% 
were male. Overall, 26 non-unique resident and 25 attending physician raters 
participated in this study. Attending physician raters were significantly eider (median, 
35 vs 31 years; P =0.002), had a longer professional experience (median, 8 vs 4 
years; P <0.001 ), and were somewhat more likely to be male than resident physician 
raters (50 vs 32%; P =0.25). Ali resident and attending physicians completed the data 
collection forms . 
Table 2 shows patient age and the prevalence of the individual PESI variables 
based on the resident and attending physician raters and interrater reliability and total 
percent agreement for these variables. Reliability coefficients ranged from 0.46 for 
respiratory rate ;::: 30/minute to 1.0 for age, gender, and chronic lung disease. Using 
conventional definitions, five variables had a near periect interrater reliability, five 
variables had a substantial interrater reliability, and one variable had a moderate 
interrater reliability. Total percent agreement varied between 92% for respiratory rate 
;::: 30/minute and 100% for gender and chronic lung disease. 
The interrater reliability between resident and attending physician raters for 
PESI point score calculation (ICC: 0.89, 95% confidence interval [Cl] : 0.81 to 0.94) 
and PESI risk class assignment was near periect (weighted K: 0.81, 95% Cl: 0.66 to 
0.94). Compared to the attending physicians,.the residents classified two patients into 
a higher PESI risk class and five patients into a lower PESI risk class (total percent 
agreement: 85%) (Table 3) . None of the rater characteristics (resident vs attending 
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physician, gender, and years of clinical experience) was significantly associated with 
the PESI total point score. 
The interrater reliability for the classification as low versus higher-risk was also 
near perfect (unweighted K: 0.92, 95% Cl: 0.72 to 0.98). The residents and attending 
physicians disagreed only on two patients (total percent agreement: 96%) (Table 4). 
ln one case, the resident failed to include the patient's age in the PESI total point 
score, which led to the erroneous classification of the patient as low-risk. ln the 
second case, the resident and attending physician disagreed as to whether the 
patient had a respiratory rate ;::: 30/minute. 
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DISCUSSION 
This study documents near periect interrater reliability between resident and 
attending physician raters for PESI risk stratification and the identification of low 
versus higher-risk patients. The interrater reliability for most individual variables that 
comprise the PESI was substantial or near periect, with reliability coefficients > 0.6 
for 10 of 11 PESI variables. Prior retrospective and prospective validation studies 
have convincingly demonstrated that the PESI accurately identifies patients with PE 
who are at low risk of death and other adverse outcomes and who are potential 
candidates of outpatient treatment or an abbreviated hospital stay (1 -4) . The present 
study demonstrates the PESl's high reproducibility among physician raters with 
varying levels of clinical experience, supporting the use of the PESI to guide the initial 
admission decision. 
Our results are consistent with a retrospective study that found a near periect 
interrater reliability between two unique physician raters for PESI point score 
calculation (ICC: 0.82) (13). The interrater reliability for PESI risk class assignment 
and the classification of patients as low versus higher-risk was lower in this study, 
with a K value of 0.57 and 0.69, respectively (13). While the K values for the individual 
variables that comprise the PESI were not reported in this study, some disagreement 
in the ascertainment of vital signs occurred in 64% of cases (13). Our findings 
indicate that the PESl's interrater reliability may be better when the PESI is 
prospectively applied by physicians while being actively involved in the care of 
patients with PE. 
Methodological guidelines for the development of clinical prediction rules 
recommend the assessment of the interrater reliability of the rule itself as well as of 
the individual predictor variables (7). According to these guidelines, predictor 
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variables with reliability coefficients < 0.6 are considered unreliable and should not be 
included in a prediction rule (7) . Although a good interrater reliability is a crucial 
component of a clinical prediction rule's internai validity, only 3% of studies on the 
development of clinical prediction rules reported any reliability measures (7). 
Although one of 11 variables included in the PESI had an interrater reliability 
below 0.6 (respiratory rate ~ 30/minute) , the clinically more relevant interrater 
reliability for assignment to one of five PESI risk classes and classification of patients 
as low versus higher-risk remained near periect, with reliability coefficients > 0.80. ln 
comparison, in a prior study examining the interrater reliability of the Wells and 
Charlotte score, two prediction rules that estimate the clinical pre-test probability of 
PE, individual predictor variables had reliability coefficients ranging from 0.5 to 0.94 
(14). The reliability coefficients for classifying patients as low, intermediate, or high-
risk of having PE (Wells score) or as "safe" versus "unsafe" (Charlotte score) were 
0.54 and 0.56, respectively (14) , although other studies reported somewhat higher 
values (15, 16). The moderate reliability coefficient for respiratory rate~ 30/minute (K: 
0.46) , an easily available and explicit variable, is somewhat surprising. A recently 
developed simplified version of the PESI that does not comprise respiratory rate and 
altered mental status as predictor variables may potentially have an even higher 
reproducibility (17). 
Our study has several strengths. First, we prospectively enrolled unselected, 
consecutive patients with PE, making a selection bias unlikely. Second, ratings were 
periormed prospectively by resident and attending physicians who were actively 
involved in the care of the patients with PE, which closely simulates real-life 
application of the PESI in the ED. Third, raters were strictly blinded to each others' 
assessment, which reduced the risk of any cross-contamination between raters and 
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preserved independence between ratings. Finally, the fact that we used two large 
groups of non-unique resident and attending physician raters rather than two unique 
raters to assess interrater reliability is likely to increase the generalizability of our 
results. 
Sorne limitations of our study should be acknowledged. First, our interrater 
reliability assessment was performed in a relatively small sample of 48 patients with 
PE and was restricted to residents and attending physicians working in the ED of a 
research-intensive teaching hospital. Thus, our results are not necessarily applicable 
to other facilities (e.g., non-teaching hospitals without major research activity) and 
settings (e.g., general internai medicine services) that are involved in the care of 
patients presenting with acute PE. lndependent confirmation of our results in larger 
studies and various settings is therefore desirable. Second, participating physicians 
may have improved their performance of the risk assessment in response to being 
observed (Hawthorne effect). Thus, we cannot entirely exclude the possibility that the 
PESl's interrater reliability may be lower outside the setting of a research study. 
ln conclusion, there was a near perfect interrater reliability between resident 
and attending physician raters for assignment to PESI risk class and classification of 
patients as low versus higher-risk. The interrater reliability for the determination of 
most individual PESI variables was substantial or near perfect. These methodological 
findings coupled with prior studies demonstrating the accuracy of the PESI to identify 
low-risk patients with PE support the use of the PESI to guide the initial admission 
decision. 
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Table 1. The Pulmonary Embolism Severity Index (PESI) 
Predictors Points Assigned 
Age, peryear Age, in years 
Male gender +10 
Cancer* +30 
Heart failure +10 
Chronic lung disease +10 
Pulse <::: 110/minute +20 
Systolic blood pressure < 1 OO mm Hg +30 
Respiratory rate <::: 30/minutet +20 
Temperature < 36°C +20 
Altered mental statustt +60 
Arterial oxygen saturation < 90%t +20 
A total point score for a given patient is obtained by summing the patient's age in years and 
the points for each applicable predictor. Points assignments correspond with the following 
risk classes: :::; 65 class 1; 66-85 class Il; 86-105 class 111; 106-125 class IV; and > 125 class 
V. Patients in risk classes 1 and 11 are defined as low-risk. 
*Defined as a history of cancer or active cancer. 
tAssessed with and without the administration of supplemental oxygen . 
tDefined as disorientation, lethargy, stupor, or coma. 
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Table 2. Agreement for the 11 individual PESI variables based on resident and attending physician assessment 
Percent or median (IQR) 
PESI predictor variables Residents Attending lnterrater reliability Total% physicians coefficient (95% Cl)* agreement 
Age, years 65 (48-77) 65 (48-77) 1.0 NA 
Male gender 56.3 56.3 1.0 (0.85-1.0) 100 
Cancer 22.9 20.8 0.94 (0.69-0.99) 98 
Heart failure 8.3 4.2 0.65 (0.19-0.90) 96 
Chronic lung disease 6.3 6.3 1.0 (0.52-1 .0) 100 
Pulse ~ 11 O/minute 16.7 18.8 079 (0.47-0.93) 94 
Systolic blood pressure < 1 OO mm Hg 4.2 6.3 0.79 (0.26-0.96) 98 
Respiratory rate ~ 30/minute 10.4 6.3 0.46 (0.09-0.78) 92 
Temperature < 36°C 12.5 12.5 0.81 (0.44-0.95) 96 
Altered mental status 2.1 4.2 0.66 (0.12-0.94) 98 
Arterial oxygen saturation < 90% 4.2 6.3 0.79 (0.26-0.96) 98 
Abbreviations: IQR = interquartile range; Cl = confidence interval ; NA = not applicable. 
*We used the unweighted kappa coefficient for categorical variables and the intraclass correlation coefficient for continuous variables. 
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Table 3. Agreement of PESI risk class assignment between residents and 
attending physicians* 
Attending physicians 
Residents Class 1 Class Il Class Ill Class IV Class V Total 
Class 1 11 1 1 0 0 13 
Class Il 1 9 0 0 0 10 
Class Ill 0 1 10 2 1 14 
Class IV 0 0 0 7 0 7 
Class V 0 0 0 0 4 4 
Total 12 11 11 9 5 48 
*Weighted kappa coefficient: 0.81 (95% Cl: 0.66 to 0.94); total percent agreement: 85%. 
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Table 4. Agreement of patient classification as low versus higher-risk between 
residents and attending physicians* 
Attending physicians 
Residents Low-risk Higher-risk Total 
Low-risk 22 23 
Higher-risk 1 24 25 
Total 23 25 48 
*Unweighted kappa coefficient: 0.92 (95% Cl: 0.72 to 0.98); total percent agreement: 96%. 
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Additional Table 
(1) What is known on this tapie 
• The Pulmonary Embolism Severity Index (PESI) is a validated clinical 
prediction rule for prognosis for patients with pulmonary embolism (PE) 
• Current methodological guidelines request that the reproducibility of a 
prediction rule and its individual predictive variables should be assessed 
before the rule can be adopted into clinical practice. 
(2) What this paper adds 
• This prospective study demonstrates that the PESI has an excellent interrater 
reliability between resident and attending physician raters 
• These methodological findings further support the use of the PESI for risk 
stratification of patients with PE 
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